|
|
|
Volumn 16, Issue 6 Suppl 6, 2002, Pages 9-15
|
|
The current status of docetaxel in solid tumors. An M. D. Anderson Cancer Center Review.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ARTICLE;
CLINICAL TRIAL;
FEMALE;
HEAD AND NECK TUMOR;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
NEOPLASM;
SQUAMOUS CELL CARCINOMA;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
FEMALE;
HEAD AND NECK NEOPLASMS;
HUMANS;
LUNG NEOPLASMS;
MALE;
NEOADJUVANT THERAPY;
NEOPLASMS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0036618064
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (34)
|
|
References (0)
|
